Golimumab Subcutaneous and Pregabalin Extended-Release Tablets
Determining the interaction of Golimumab Subcutaneous and Pregabalin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: pregabalin
Brand name: Lyrica, Lyrica CR
Synonyms: Pregabalin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Pregabalin Oral Solution
- Golimumab Subcutaneous-Pregnyl
- Golimumab Subcutaneous-Pregnyl injectable
- Golimumab Subcutaneous-Prelidopine Pre-Operative System
- Golimumab Subcutaneous-Prelone
- Golimumab Subcutaneous-Prelu-2
- Pregabalin Extended-Release Tablets-GoLYTELY
- Pregabalin Extended-Release Tablets-Gonadorelin
- Pregabalin Extended-Release Tablets-Gonadorelin Intravenous, Injection
- Pregabalin Extended-Release Tablets-Gonadotropin, Chorionic
- Pregabalin Extended-Release Tablets-Gonal-F
- Pregabalin Extended-Release Tablets-Gonal-f RFF